) carrying the high affinity determinants of the DHP receptor site but inactivating at different rates. Ca 2؉ channel inactivation was modulated by coexpressing the ␣ 1A-DHP -or ␣ 1Lc -subunits in Xenopus oocytes with either the ␤ 2a -or the ␤ 1a -subunit and amino acid substitutions in L-type segment IVS6 (I1497A, I1498A, and V1504A). Contrary to a modulated receptor mechanism assuming high affinity DHP binding to the inactivated state we observed no clear correlation between steady state inactivation and Ca 2؉ channel block by (؉)-isradipine: (i) a 3-fold larger fraction of ␣ 1A-DHP /␤ 1a channels in steady state inactivation at ؊80 mV (compared with ␣ 1A-DHP /␤ 2a ) did not enhance the block by (؉)-isradipine; (ii) different steady state inactivation of ␣ 1Lc mutants at ؊30 mV did not correlate with voltage-dependent channel block; and (iii) the midpoint-voltages of the inactivation curves of slowly inactivating L-type constructs and more rapidly inactivating ␣ 1Lc /␤ 1a channels were shifted to a comparable extent to more hyperpolarized voltages. A kinetic analysis of (؉)-isradipine interaction with different Ltype channel constructs revealed a drug-induced inactivated state. Entry and recovery from drug-induced inactivation are modulated by intrinsic inactivation determinants, suggesting a synergism between intrinsic inactivation and DHP block.
Ca
2ϩ channels are hetero-oligomeric protein complexes consisting of a pore-forming ␣ 1 -subunit, one out of at least four ␤-subunits (␤ 1 -␤ 4 ), an ␣ 2 /␦-subunit, and in skeletal muscle an additional ␥-subunit (3, 4) . The auxiliary channel subunits, in particular the ␤-subunits, modulate voltage dependence, expression density, and kinetics of Ca 2ϩ channels (for review see Ref. 4) . There is biochemical evidence that multiple ␤-subunits are associated with the ␣ 1 -subunit, suggesting a tissue-specific modulation of Ca 2ϩ channel properties by different ␤-subunit expression patterns (5, 6) .
The ␣ 1 -subunits of L-type Ca 2ϩ channels (classes C (formed by ␣ 1C -subunits), D (formed by ␣ 1D -subunits), and S (formed by ␣ 1S -subunits)) possess drug receptors for 1,4-dihydropyridines (DHPs), 1 phenylalkylamines, and benzothiazepines (7, 8) . Mutational analysis of L-type Ca 2ϩ channel ␣ 1 -subunits revealed nine amino acid residues in segments IIIS5, IIIS6, and IVS6 that confer high affinity and stereoselective interaction with DHPs (2, 9 -13).
According to the modulated receptor hypothesis (14) , the interaction of an ion channel blocker with its receptor sites depends on whether the channel is in a resting (closed), open (activated), or inactivated (closed) conformational state. This hypothesis was applied to Ca 2ϩ channel block by organic calcium channel blockers such as phenylalkylamines, benzothiazepines, and DHPs (15, 16) . In the frame of a specific version of the modulated receptor model, the more efficient Ca 2ϩ channel inhibition by DHPs at depolarized membrane potentials is interpreted as predominant block of inactivated channels. Accordingly, stronger DHP antagonist action in the depolarized vascular tissue was suggested to reflect a more efficient block of inactivated Ca 2ϩ channels (but see Refs. 17 and 18). To elucidate the role of the inactivated channel conformation in the molecular mechanism of Ca 2ϩ channel block by DHPs, we have designed Ca 2ϩ channels inactivating at different rates by co-expressing a L-type channel construct ␣ 1Lc (1) or the DHP-sensitive class A Ca 2ϩ channel mutant ␣ 1A-DHP (2) with either ␤ 1a -or ␤ 2a -subunits. Additionally, Ca 2ϩ channel inactivation was modulated by introducing point mutations into segment IVS6 of ␣ 1Lc . The consequences of changed inactivation properties for (ϩ)-isradipine-induced block were analyzed by means of the two-microelectrode voltage clamp technique after expression in Xenopus oocytes. We observed no clear correlation between the amount of steady state inactivation and voltagedependent block by (ϩ)-isradipine. Our data support a hypothesis where the inactivation gating of Ca 2ϩ channels is accelerated in their antagonist DHP-bound form. Channel constructs with impaired fast inactivation displayed faster recovery from block by (ϩ)-isradipine, suggesting a close interdependence between intrinsic inactivation determinants and the (ϩ)-isradipine-induced inactivated state.
nucleotide numbering of ␣ Lc and mutants derived thereof is according to ␣ 1C-a cDNA sequence (19) . All mutations were introduced by polymerase chain reaction as described previously (10) . Fragments amplified by polymerase chain reaction were sequenced entirely to confirm sequence integrity.
Electrophysiology-Inward barium currents (I Ba ) were studied with two microelectrode voltage-clamp of Xenopus oocytes 2-7 days after microinjection of approximately equimolar cRNA mixtures of ␣ 1Lc or ␣ 1A-DHP (2) (0.3 ng/50 nl) together with ␣ 2 ␦ (0.2 ng/50 nl) and either ␤ 1a (0.1 ng/50 nl) or ␤ 2a (0.1 ng/50 nl) cRNA as described previously (10) . The corresponding constructs were named ␣ 1Lc/A-DHP /␤ 1a or ␣ 1Lc/A-DHP / ␤ 2a channels. Mutant ␣ 1Lc -subunits (named herein I1497A, I1498A, and V1504A; see above) were coexpressed with ␣ 2 ␦ and the ␤ 1a -subunit exclusively.
All experiments were carried out at room temperature in a bath solution with the following composition: 40 mM Ba(OH) 2 , 50 mM NaOH, 5 mM HEPES, 2 mM CsOH (pH adjusted to 7.4 with methanesulfonic acid). Voltage recording and current injecting microelectrodes were filled with 2.8 M CsCl, 0.2 M CsOH, 10 mM EGTA, 10 mM HEPES (pH 7.4) and had resistances of 0.3-2 M⍀. Resting channel block was estimated as peak I Ba inhibition during 100-ms test pulses from Ϫ80 to 20 mV at a frequency of 0.033 Hz until steady state was reached. The dose response curves of I Ba inhibition were fitted using the Hill equation: I Ba, drug /I Ba, control (as percentages) ϭ (100 Ϫ A)/(1 ϩ (C/IC 50 ) nH ) ϩ A, where IC 50 is the concentration at which I Ba inhibition is half-maximal, C is the applied drug concentration, A is the fraction of I Ba that is not blocked, and n H is the Hill coefficient.
Recovery from inactivation was studied at a holding potential of Ϫ80 mV after depolarizing Ca 2ϩ channels during a 3-s prepulse to 20 mV by applying 30-ms test pulses (to 20 mV) at various time intervals after the conditioning prepulse. Peak I Ba values were normalized to the peak current measured during the prepulse, and the time course of I Ba recovery from inactivation was fitted to a mono-or biexponential func-
Voltage dependence of inactivation under quasi-steady state conditions was measured using a multi step protocol to account for run-down (less than 10%). A control test pulse (50 ms to 20 mV) was followed by a 1.5-s step to Ϫ100 mV followed by a 30-s conditioning step, a 4-ms step to Ϫ100 mV, and a subsequent test pulse to 20 mV (corresponding to the peak potential of the I-V curves).
Inactivation during the 30 s conditioning pulse was calculated as follows.
I Ba, inactivation ϭ 1 Ϫ I Ba,test (20 mV)/I Ba,control (20 mV) (Eq. 1)
The pulse sequence was applied every 3 min from a holding potential of Ϫ100 mV. Inactivation curves were drawn according to the following Boltzmann equation.
where V is the membrane potential, V 0.5 is the midpoint voltage, k is the slope factor, and I ss is the fraction of noninactivating current. Steady state inactivation of ␣ 1A-DHP and ␣ 1Lc channels at Ϫ80 mV was estimated by shifting the membrane holding potential from Ϫ80 to Ϫ100 mV (␣ 1Lc ) or Ϫ120 mV (␣ 1A-DHP ). Subsequent monitoring of the corresponding changes in I Ba amplitudes until steady state revealed the fraction of Ca 2ϩ channels in the inactivated state at Ϫ80 mV. Steady state inactivation of different L-type channel constructs at Ϫ30 mV was estimated by fitting time course of current inactivation to a biexponential function (see Fig. 4A ).
The I Ba inactivation time constants were estimated by fitting the I Ba decay to a mono or biexponential function. Data are given as the means Ϯ S.E. Statistical significance was calculated according to Student's unpaired t test.
RESULTS

␤-Subunit Regulation of Ca
2ϩ Channel Inactivation and Block by (ϩ)-Isradipine-To evaluate the role of ␤-subunit mediated inactivation in Ca 2ϩ channel block by isradipine, we coexpressed the ␣ 1Lc (1) and ␣ 1A-DHP -subunits (2) together with either the ␤ 1a -or the ␤ 2a -subunit and analyzed peak current inhibition by its high affinity (ϩ)-enantiomer. In line with previous observations (20) , ␣ 1Lc /␤ 2a channels displayed slower inactivation kinetics than ␣ 1Lc /␤ 1a channels ( Fig. 1) . At Ϫ80 mV ␣ 1Lc /␤ 1a channels displayed slightly more steady state inactivation than ␣ 1Lc /␤ 2a channels (p Ͼ 0.05; Fig. 1D ). Slowly inactivating ␣ 1Lc /␤ 2a channels were blocked by (ϩ)-isradipine with a half-maximal inhibitory concentration of 198 Ϯ 35 nM (n ϭ 3), which was not statistically different from block of more rapidly inactivating ␣ 1Lc /␤ 1a channels (IC 50 ϭ 327 Ϯ 41 nM, p Ͼ 0.05; Fig. 1A ).
The DHP-sensitive class A Ca 2ϩ channel mutant ␣ 1A-DHP inactivates at a faster rate than L-type channels and displays an inactivation curve that is, compared with L-type channels, significantly shifted into the hyperpolarizing direction (2). The slightly higher DHP sensitivity of this channel construct compared with L-type channels could therefore reflect a more efficient drug interaction with the inactivated channel state at Ϫ80 mV.
To test this hypothesis we coexpressed the ␣ 1A-DHP -subunit with different ␤-subunits and analyzed the (ϩ)-isradipine sensitivity of the two channel constructs inactivating at different rates. As shown for ␣ 1Lc /␤ 2a (Fig. 1B) , coexpression of the ␤ 2a -subunit dramatically slowed the inactivation time course of the resulting ␣ 1A-DHP /␤ 2a channels (Fig. 2B) . Furthermore, at Ϫ80 mV we observed a 3-fold larger steady state fraction of Fig. 2D ). A modulated receptor mechanism implying high affinity block of inactivated channels would predict a more pronounced inhibition of ␣ 1A-DHP/␤ 1a channels. The concentration of (ϩ)-isradipine for halfmaximal block of I Ba in ␣ 1A-DHP /␤ 1a channels (IC 50 ϭ 61 Ϯ 14, n ϭ 4) at Ϫ80 mV was, however, not significantly different from ␣ 1A-DHP /␤ 2a (IC 50 ϭ 52 Ϯ 14, p Ͼ 0.05; Fig. 2A ). These data clearly indicate that enhanced inactivation did not cause stronger I Ba inhibition of ␣ 1A-DHP /␤ 1a channels.
Inactivation Determinants in Segment IVS6 Affect Ca 2ϩ
Channel Block by (ϩ)-Isradipine-To evaluate the role of channel inactivation determinants in the pore forming ␣ 1Lc -subunit for channel block by (ϩ)-isradipine, we replaced three amino acids in segment IVS6 of ␣ 1Lc by alanine (I1497A, I1498A, and V1504A) and analyzed the DHP sensitivity of the resulting mutants.
As shown in Fig. 3A , alanine substitutions of the two puta- At a holding potential of Ϫ80 mV, the fraction of inactivated channels was not significantly different between the various L-type channel constructs (ranging from 5 Ϯ 2% (V1504A, n ϭ 5) to 3 Ϯ 1% (␣ 1Lc /␤ 1a , n ϭ 5)). The observed changes in drug sensitivity at Ϫ80 mV appear, therefore, to be associated with a more pronounced resting channel block.
Steady state Inactivation and Voltage-dependent L-type Ca 2ϩ
Channel Block-To evaluate the role of the inactivated channel conformation of our L-type constructs as high affinity receptor for (ϩ)-isradipine, we estimated the steady state inactivation at Ϫ30 mV (see pulse protocol in inset of Fig. 4A ). Different channel constructs displayed significantly different steady state inactivation at Ϫ30 mV (ranging in the absence of drug between 9 Ϯ 1% (␣ 1Lc /␤ 1a , n ϭ 5) and 21 Ϯ 3% (I1498A, n ϭ 4)) (Fig. 4, C and D) . We did, however, not observe a simple relation between inactivation and voltage-dependent channel block by (ϩ)-isradipine. As illustrated in Fig. 4 (A and B) , a higher fraction of steady state inactivation in ␣ 1Lc /␤ 2a channels did not result in a stronger voltage-dependent channel block compared with ␣ 1Lc /␤ 1a channels. Compared with its effect on ␣ 1Lc /␤ 1a channels (56 Ϯ 3% additional current inhibition, n ϭ 4), the drug induced significantly less channel block in ␣ 1Lc /␤ 2a (40 Ϯ 4%), I1498A (25 Ϯ 2%), and V1504A channels (34 Ϯ 5%, n Ͼ 7; Fig.  4C ). Plotting the fraction of steady state inactivation of the different L-type channel mutants at Ϫ30 mV against the amount of drug-induced inactivation revealed even a reversed correlation (r ϭ 0.94) between these two parameters (Fig. 4D) .
The different inactivation properties of constructs ␣ 1Lc /␤ 1a , ␣ 1Lc /␤ 2a , I1498A, and V1504A prompted us to analyze the voltage dependence of channel inactivation in control and the presence of (ϩ)-isradipine in more detail. The inactivation curves (measured with 30 s conditioning prepulses) in control and the presence of 10 nM, 100 nM, and 1 M (ϩ)-isradipine are illustrated in Fig. 5 . The midpoint voltages of the inactivation curves of all four L-type constructs were shifted to a comparable extent in the hyperpolarizing direction ( Fig. 5 and Table I) . A modulated receptor mechanism would predict a correlation between channel inactivation during the conditioning prepulses and voltage-dependent channel block. No such correlation was observed.
Kinetics of Drug-induced Inactivation at Ϫ30 mV-Ca 2ϩ channel inactivation at Ϫ30 mV developed with a biexponential time course (Fig. 4) . (Fig. 4, A and B) . These findings suggest that (ϩ)-isradipine promotes a channel conformation resembling intrinsic fast inactivation. The fraction of channels in this new drug-induced inactivated state correlated with the drug-induced steady state inactivation (Fig. 4C) . 
Isradipine-induced Ca 2ϩ Channel Inactivation(ϩ)-Isradipine-induced Changes in I Ba
Kinetics at 20 mV-(ϩ)-Isradipine-induced changes in I Ba kinetics at 20 mV are illustrated in Fig. 6 . The drug (1 M) accelerated the fast component in I Ba decay of ␣ 1Lc /␤ 1a from fast, control ϭ 415 Ϯ 52 ms to fast, isradipine ϭ 166 Ϯ 9 ms (n ϭ 7). In ␣ 1Lc /␤ 2a and V1504A channels I Ba inactivation developed with slow time constants of 16 Ϯ 2 s (␣ 1Lc /␤ 2a ) and 12 Ϯ 2 s (V1504A, n ϭ 5), indicating complete absence of intrinsic fast inactivation (see also corresponding recovery experiments in Fig. 7 ). (ϩ)-Isradipine induced in both channel constructs a transient component in the current decay with similar time constants of fast, isradipine (V1504A) ϭ 215 Ϯ 35 ms and fast, isradipine (␣ 1Lc /␤ 2a ) ϭ 210 Ϯ 30 ms (n ϭ 5). The slow inactivation time constants of the I Ba decay were not significantly affected by the drug (see right column of Fig. 6 and inset in Fig. 6A ).
Mutation I1498A reduced Ca 2ϩ channel inactivation (Fig.  3A) and simultaneously accelerated fast inactivation ( fast, control ϭ 155 Ϯ 20 ms, p Ͻ 0.01 compared with 415 Ϯ 52 ␣ 1Lc /␤ 1a ; see also Fig. 6C) . Irrespective of the changes in channel inactivation in I1498A channels, drug-induced acceleration of the current occurred at a similar rate as in ␣ 1Lc /␤ 1a channels ( fast, isradipine ϭ 142 Ϯ 18 ms, n ϭ 6, Fig. 6, A and C) . Thus, (ϩ)-isradipine-induced acceleration of the current decay occurred in all L-type channel constructs at a comparable rate.
Recovery from Voltage-dependent Block by (ϩ)-Isradipine-I Ba recovery of ␣ 1Lc /␤ 1a channels at Ϫ80 mV was well described by a monoexponential function ( rec, control ϭ 0.65 Ϯ 0.07 s, n ϭ 6; Fig. 7A ). Recovery in the presence of 1 M (ϩ)-isradipine was about four times slower ( rec, drug ϭ 2.80 Ϯ 0.14 s, n ϭ 4; Fig. 7 , A and E), suggesting that the drug promotes a new (druginduced) inactivated state.
Regardless of the complete absence of intrinsic "fast inactivation" in ␣ 1Lc /␤ 2a and V1504A channels (Fig. 6, B and D) , 
, C-E).
Mutant I1498A recovered with biexponential kinetics in control (Fig. 7B) . (ϩ)-Isradipine enhanced the impact of the fast component (Fig. 7F) . However, the drug did not slow the time course of I Ba recovery in I1498A channels. Neither the recovery time constant from fast inactivation nor recovery from slow inactivation were significantly affected by (ϩ)-isradipine ( rec, control ϭ 471 Ϯ 50 ms, rec, drug ϭ 453 Ϯ 45 ms, n ϭ 4; see also Fig. 7, B and E) . Recovery of I1498A channels from inactivation in the presence of (ϩ)-isradipine occurred at a 6-fold faster rate the recovery of ␣ 1Lc /␤ 1a channels, suggesting a particularly important role of Ile 1498 in stabilization of the DHPinduced inactivated state.
DISCUSSION
According to a widely accepted hypothesis, DHPs bind with high affinity to the inactivated state of Ca 2ϩ channels (15, 16 (Fig. 3A) . Alanine substitutions of these amino acids slowed I Ba inactivation and increased the apparent DHP sensitivity at Ϫ80 mV (Fig. 3) . Slowing the kinetics of ␣ 1Lc channels by coexpression of the ␤ 2a -subunit had no significant effect on I Ba inhibition (Figs. 1 and 3) . However, neither co-expression of the different ␣ 1Lc mutants with the ␤ 2a -subunit nor introducing point mutations into segment IVS6 significantly affected the steady state fraction of channels in the inactivated state at Ϫ80 mV. Our measurements of drug action at Ϫ80 mV therefore primarily provided information Table I .
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about an enhanced resting state affinity of constructs I1497A, I1498A, and V1504A. Fig. 2 , we estimated at Ϫ80 mV an about 3-fold larger fraction of ␣ 1A-DHP /␤ 1a channels in steady state inactivation than in ␣ 1A-DHP /␤ 2a . Despite this marked difference, ␣ 1A-DHP /␤ 1a and ␣ 1A-DHP /␤ 2a channels were blocked with similar IC 50 values (␣ 1A-DHP /␤ 1a , 61 Ϯ 14; ␣ 1A-DHP /␤ 2a , 52 Ϯ 14; p Ͼ 0.05).
Role of Inactivation in ␣ 1A-DHP Channel Block by (ϩ)-Isradipine-As illustrated in
This result is hard to explain in the frame of a modulated receptor model suggesting high affinity drug binding to the inactivated channel conformation. Instead, our data clearly demonstrate that ␤-subunit-induced changes in the steady state fraction of channel inactivation at Ϫ80 mV have no significant effect on (ϩ)-isradipine sensitivity of ␣ 1A-DHP channels. A higher sensitivity of mutant ␣ 1A-DHP /␤ 1a (IC 50 ϭ 61 Ϯ 14) compared with the L-type construct ␣ 1Lc /␤ 1a (IC 50 ϭ 327 Ϯ 41, p Ͻ 0.01) therefore cannot be explained by a high affinity block of a larger fraction of ␣ 1A-DHP channels in an inactivated state. A loss in voltage dependence of DHP block caused by the class A sequence environment of the DHP-binding site in ␣ 1A-DHP cannot be excluded.
Role of Inactivation in L-type Ca 2ϩ Channel Block by (ϩ)-Isradipine-Next we exploited the different inactivation properties of our L-type Ca
2ϩ channel constructs to analyze whether a larger steady state fraction of inactivated channels at Ϫ30 mV would enhance voltage-dependent channel block. As shown in Fig. 4D , we observed even a reversed correlation between these two parameters.
This apparent discrepancy with a high affinity drug binding mechanism to the inactivated channel state is also illustrated in Fig. 5 . Removal of fast inactivation in V1504A and in ␣ 1Lc / ␤ 2a channels substantially reduced the fraction of inactivated channels during the 30-s conditioning pulses compared with ␣ 1Lc /␤ 1a (Fig. 5, A-C) . We observed, however, no correlation between the shifts in the midpoint voltages of the inactivation curves in the presence of 10 nM to 1 M (ϩ)-isradipine (Table I) and the amount of inactivation during a 30-s conditioning test pulse (more than 90% in ␣ 1Lc /␤ 1a channels versus about 70% in ␣ 1Lc /␤ 2a and V1504A channels). These data suggest that drug binding to the inactivated state is less crucial for L-type channel block than previously supposed.
The kinetics of the voltage-dependent channel block by (ϩ)-isradipine at Ϫ30 mV support, however, the hypothesis that the drug promotes a conformational state resembling intrinsic fast inactivation (Fig. 4, A and B) . As demonstrated in Fig. 4 , the formation of this "drug-induced inactivated state" was modulated by intrinsic determinants of fast inactivation in segment IVS6 and ␣ 1 -␤-subunit interaction.
At 20 mV (ϩ)-isradipine (1 M) accelerated the I Ba decay of all L-type channel constructs to a comparable extent (Fig. 6) . At this potential drug-induced acceleration of the current decay could be due to rapid open channel block (21), drug-induced inactivation, or both. It is tempting to speculate that the (ϩ)-isradipine-induced acceleration of the current decay at 20 mV at least partially reflects drug-induced transitions of open channels to an inactivated state that was observed for resting channels at Ϫ30 mV (Fig. 4, A and B) . However, state transitions of resting channels at Ϫ30 mV cannot be extrapolated to 20 mV, where inactivation occurs predominantly from the open state. More detailed studies including an analysis of the dose dependence of (ϩ)-isradipine-induced changes in I Ba kinetics at different membrane voltages are required to answer this question.
Intrinsic Inactivation Determinants in Segment IVS6 Affect Recovery from (ϩ)-Isradipine Block-As shown in Fig. 7 , constructs ␣ 1Lc /␤ 2a ( rec, drug ϭ 2.26 Ϯ 0.23 s, n ϭ 5) and V1405A ( rec, drug ϭ 1.48 Ϯ 0.48 s, n ϭ 4) recovered from the druginduced inactivation with slightly faster time constants than ␣ 1Lc /␤ 1a ( rec, drug ϭ 2.80 Ϯ 0.14 s, n ϭ 4, p ϭ 0.05). Most dramatic effects were observed for amino acid substitution I1498A. This mutant recovered in (ϩ)-isradipine much faster from inactivation ( rec, drug ϭ 0.45 Ϯ 0.05 s, n ϭ 4) than ␣ 1Lc /␤ 1a and the other constructs (Fig. 7E) . This property distinguishes Ile 1498 from other IVS6 residues investigated in the present study (Fig. 7B) . A simple interpretation of these results is that mutation I1498A and to a lesser extent mutation V1405A and the ␣ 1Lc -␤ 2a interaction destabilize the drug-induced inactivated state (Fig. 8) .
Implications for the Molecular Mechanism of DHP Action-A role of channel inactivation determinants in different sequence stretches of L-type and non-L-type ␣ 1 -subunits in block by An interesting question about the interaction of DHPs with Ca 2ϩ channels is whether these drugs bind with high affinity to the inactivated state or whether the inactivation gating of the channels in their drug-bound form is changed. In his original work on the modulated receptor hypothesis, Hille (25) stressed both ways of expressing the concept of the modulated receptor hypothesis.
The aim of the present study was to distinguish the impact of drug binding to the inactivated state from drug-induced inactivation by making use of DHP-sensitive Ca 2ϩ channel constructs with different inactivation properties. We report here almost identical (ϩ)-isradipine sensitivity of ␣ 1A-DHP /␤ 1a and ␣ 1A-DHP /␤ 2a channels despite the pronounced differences in steady state inactivation (Fig. 2) . For our L-type mutants, we observed at Ϫ30 mV even a reversed correlation between the different channel fractions in inactivation and voltage-dependent channel block (Fig. 4D) . Both findings are inconsistent with a modulated receptor mechanism implying an interdependence between high affinity DHP-binding to Ca 2ϩ channels in an inactivated state and drug-induced inactivation.
We hypothesize that drug-induced changes in the availability curve reflect the formation of a new (ϩ)-isradipine-induced inactivated channel conformation. Recovery from drug-induced inactivation is modulated by intrinsic inactivation determinants, suggesting a synergism between both processes (most prominent for mutation I1498A).
The possible structural implications of our data are hard to interpret. On one hand, this interrelationship may indicate that conformational changes during channel inactivation modulate the orientation of DHP-binding determinants; on the other hand, they may also reflect an overlap between drug binding and inactivation determinants (see Fig. 8 for illustration) .
In conclusion, DHP-sensitive Ca 2ϩ channel constructs with different inactivation properties represent valuable tools for studying the role of the inactivated channel conformation in DHP block. The characterization of the drug-induced inactivated conformational state(s) and the identification of further structural links between the DHP-binding sites and intrinsic 2ϩ channels in the presence of (ϩ)-isradipine suggests that the drug stabilizes a new inactivated channel conformation ( Fig. 7A ; see also Ref. 26) . The scheme illustrates an interdependence between intrinsic inactivation properties and the stability of the (ϩ)-isradipine-induced conformation. Amino acid substitution I1498A induced a 6-fold faster I Ba recovery from the drug-induced state, and an about 2-fold faster recovery was observed for mutant V1504A. Faster recovery of ␣ 1Lc /␤ 2a channels was significant (compared with ␣ 1Lc /␤ 1a ) but less pronounced ( Fig. 7 ; see also Ref. 26 ).
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channel inactivation is an exciting subject for future mutational studies.
